Rituximab: active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
Ruhstaller
T W
TW
Amsler
U
U
Cerny
T
T
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D002420:Cauda Equina / Q000473:pathology; D003131:Combined Modality Therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000532:radiotherapy; D008279:Magnetic Resonance Imaging; D008297:Male; D010524:Peripheral Nervous System Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab